T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.76B |
| 2 |
Eli Lilly
LLY
|
+$1.4B |
| 3 |
Bank of America
BAC
|
+$1.3B |
| 4 |
Tesla
TSLA
|
+$1.19B |
| 5 |
Wells Fargo
WFC
|
+$784M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$6.47B |
| 2 |
Amazon
AMZN
|
+$3.71B |
| 3 |
Yum! Brands
YUM
|
+$2.84B |
| 4 |
Salesforce
CRM
|
+$2.77B |
| 5 |
Fortive
FTV
|
+$2.41B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.06% |
| 2 | Healthcare | 18.72% |
| 3 | Consumer Discretionary | 14.62% |
| 4 | Financials | 10.36% |
| 5 | Communication Services | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
First Commonwealth Financial
FCF
$2.18B
| $424K | ﹤0.01% |
33,003
+6,161
| +23% | +$86.4K |
|
2202
Pulmonx
LUNG
$98.4M
| $424K | ﹤0.01% |
25,396
+2,033
| +9% | +$37.4K |
|
|
CDMO
2203
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $424K | ﹤0.01% |
22,174
+3,885
| +21% | +$70.8K |
|
2204
iShares Biotechnology ETF
IBB
$9.77B
| $423K | ﹤0.01% |
3,614
| – | – |
|
2205
Marathon Digital Holdings
MARA
$3.56B
| $423K | ﹤0.01% |
39,458
+8,124
| +26% | +$96.2K |
|
2206
Standard Motor Products
SMP
$877M
| $421K | ﹤0.01% |
12,931
+1,208
| +10% | +$48.1K |
|
|
WSR
2207
DELISTED
Whitestone REIT
WSR
| $418K | ﹤0.01% |
49,340
+2,772
| +6% | +$28.5K |
|
|
MFA
2208
MFA Financial
MFA
$925M
| $417K | ﹤0.01% |
53,532
+8,270
| +18% | +$92.4K |
|
2209
Under Armour Class C
UA
$2.2B
| $414K | ﹤0.01% |
69,254
+21,347
| +45% | +$167K |
|
2210
Alpha and Omega Semiconductor
AOSL
$916M
| $413K | ﹤0.01% |
13,421
+1,284
| +11% | +$47.5K |
|
2211
Arrow Financial
AROW
$723M
| $413K | ﹤0.01% |
14,748
+845
| +6% | +$26.2K |
|
2212
Camden National
CAC
$990M
| $413K | ﹤0.01% |
9,679
+838
| +9% | +$38.1K |
|
|
HIBB
2213
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $413K | ﹤0.01% |
8,289
-458,214
| -98% | -$24.1M |
|
|
LADR
2214
Ladder Capital
LADR
$1.25B
| $412K | ﹤0.01% |
45,877
+7,487
| +20% | +$82.6K |
|
2215
MannKind Corp
MNKD
$1.24B
| $412K | ﹤0.01% |
133,194
+14,927
| +13% | +$56.3K |
|
2216
Enviri
NVRI
$583M
| $412K | ﹤0.01% |
109,939
-19,109
| -15% | -$106K |
|
2217
SSR Mining
SSRM
$6.49B
| $412K | ﹤0.01% |
27,954
+15,137
| +118% | +$228K |
|
2218
Golar LNG
GLNG
$5.2B
| $411K | ﹤0.01% |
16,473
+6,823
| +71% | +$170K |
|
2219
iShares Core S&P Small-Cap ETF
IJR
$113B
| $411K | ﹤0.01% |
4,703
| – | – |
|
2220
Harmony Biosciences
HRMY
$2.32B
| $410K | ﹤0.01% |
9,242
+1,740
| +23% | +$84.9K |
|
2221
Central Pacific Financial
CPF
$1B
| $408K | ﹤0.01% |
19,699
+1,596
| +9% | +$36K |
|
2222
Accuray
ARAY
$32.9M
| $406K | ﹤0.01% |
194,994
+65,000
| +50% | +$148K |
|
2223
Atara Biotherapeutics
ATRA
$83.1M
| $405K | ﹤0.01% |
4,278
+2,513
| +142% | +$282K |
|
2224
Conduent
CNDT
$241M
| $405K | ﹤0.01% |
121,182
-5,882,085
| -98% | -$24.5M |
|
2225
Zumiez
ZUMZ
$318M
| $404K | ﹤0.01% |
18,702
+938
| +5% | +$24.5K |
|
Similar funds
T. Rowe Price Associates's Q3 2022 Portfolio in Review
As of Q3 2022, T. Rowe Price Associates held 3,114 positions worth $610B, down 23% from $791B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
T. Rowe Price Associates withdrew a net $168B in Q3 2022, closing 171 positions and reducing 1,248 holdings. Its most notable exit was Alcon, an estimated $1.51B position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, T. Rowe Price Associates opened a new position in Corebridge Financial worth $194M.
- T. Rowe Price Associates's largest Q3 2022 buy was Corebridge Financial: 9,831,688 shares worth $194M.
- T. Rowe Price Associates added most to ExxonMobil in Q3 2022, an estimated $1.76B increase.
- T. Rowe Price Associates's biggest Q3 2022 reduction was Microsoft, cutting an estimated $6.47B.
- T. Rowe Price Associates fully exited Alcon in Q3 2022, selling an estimated $1.51B.
- T. Rowe Price Associates's ten largest holdings make up 31% of its $610B portfolio in Q3 2022.
- T. Rowe Price Associates opened 154 new positions and closed 171 in Q3 2022.
- T. Rowe Price Associates's portfolio value fell 23% quarter-over-quarter to $610B.
Based on T. Rowe Price Associates's 13F filing for Q3 2022, filed 14 Nov 2022.